Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte BLOG

Customer Spotlight: SEngine Precision Medicine
MONDAY, OCTOBER 23, 2017
linkedin twitter facebook |  3Shares

The complex analysis of multiple data types is greatly needed in precision medicine, according to Fred Hutchinson Cancer Research Center scientist Carla Grandori. She’s striving to meet that need via SEngine, a Seattle-based enterprise that harnesses the power of genomics and robotics to create truly tailored treatment assessments for those with cancer.


Labcyte technology is helping the cutting-edge company search for new drug targets and test existing drugs and drug combinations on individual tumor samples and patient-derived organoids.


“What I think makes our company unique is how we merge multiple technologies and top expertise in several branches of cancer biology, genomics and drug sensitivity,” Grandori says.


The Labcyte system allows her to rapidly test drug combinations and makes possible what other lab instruments cannot.


“The Echo Liquid Handler's power and accuracy for samples in a very miniaturized format is unparalleled,” she says.


Learn more about the company and its approach to functional drug screening in this customer profile.


»  READ CUSTOMER PROFILE